MedTrace Logo

Effects of AkPharma's Calcium Glycerophosphate Nasal Spray Wash

NCT01647633 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2015-05-25

No results posted yet for this study

Summary

Over 20 million Americans have allergic nasal symptoms including stuffiness, sneezing and a "runny" nose. AkPharma's Calcium Glycerophosphate used as a nasal spray wash is believed to improve these symptoms without side effects common to over the counter and prescription medication. It is hypothesized that Calcium Glycerophosphate will have a perceived improvement in breathing comfort.

Conditions

  • Allergic Rhinitis

Interventions

OTHER

Calcium Glycerophosphate Nasal Spray Wash

Nasal wash two to six times per day

Sponsors & Collaborators

  • AkPharma Inc.

    collaborator INDUSTRY

  • Drexel University

    lead OTHER

Principal Investigators

  • Edward S Schulman, MD · Drexel University College of Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2015-04-30
Completion
2015-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01647633 on ClinicalTrials.gov